Company: CERO
Filing Date: 2025-01-21
Form Type: S-1/A
Source: 0001213900-25-004742
Chunk: 11

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-01-21
Form: S-1/A
Chunk 11
---
 of CERo. “ Series A Warrants” refers to warrants to purchase Common Stock, at a current exercise price of $139.00 per share, sold to certain PIPE Investors pursuant to the First Securities Purchase Agreement. “ Series B Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series B Preferred Stock, as amended from time to time. “ Series B Preferred Stock” refers to the Series B convertible preferred stock, $0.0001 par value per share, of CERo. “ Series C Certificate of Designations” refers to the Certificate of Designations of Rights and Preferences of the Series C Preferred Stock, as amended from time to time. viii “ Series C Preferred Stock” refers to the Series C convertible preferred stock, $0.0001 par value per share, of CERo. “ Series C Warrants” refers to warrants to purchase shares of Common Stock, at a current exercise price of $9.80 per share, sold to certain PIPE Investors pursuant to the Third Securities Purchase Agreement. “ Sponsor” refers to Phoenix Biotech Sponsor, LLC, a Delaware limited liability company. “ Tertiary Earnout Shares” refer to the 10,000 shares of Common Stock issued to the holders of Legacy CERo common stock and Legacy CERo preferred stock in connection with the Business Combination, which will be fully vested upon the achievement of certain regulatory milestone-based earnout targets. “ Third PIPE Financing” refers to the private placement pursuant to which we issued and sold, and the PIPE Investors purchased, shares of Series C Preferred Stock, on the terms and conditions set forth in the Third Securities Purchase Agreement. “ Third PIPE Registration Rights Agreement” refers to the Registration Rights Agreement, dated as of September 26, 2024, by and between CERo and certain PIPE Investors. “ Third Securities Purchase Agreement” refers to the Securities Purchase Agreement, dated as of September 25, 2024, by and among CERo and certain PIPE Investors, pursuant to which CERo agreed to issue and sell 2,853 shares of Series C Preferred Stock and warrants to purchase 81,752 shares of Common Stock (the “Series C Warrants”). “ Warrant Common Shares” refer to the shares of Common Stock underlying the Common Warrants. “ Warrant Preferred Shares” refer to the shares of Preferred Stock underlying the Preferred Warrants “ Warrants” refer to the Rollover Warrants, the Private Placement Warrants, the Common Warrants, the